Published in Pharmacol Ther on May 01, 1995
Production of beta-defensins by human airway epithelia. Proc Natl Acad Sci U S A (1998) 3.85
The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci U S A (1998) 3.83
Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest (1998) 3.78
Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob Agents Chemother (1997) 3.12
Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc Natl Acad Sci U S A (1998) 3.02
Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun (2000) 2.24
Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect Immun (1999) 2.19
The innate immune system in cystic fibrosis lung disease. J Clin Invest (1999) 1.93
Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol (2004) 1.91
Antimicrobial polypeptides in host defense of the respiratory tract. J Clin Invest (2002) 1.67
Interaction of antimicrobial peptide protegrin with biomembranes. Proc Natl Acad Sci U S A (2003) 1.61
Mouse beta-defensin 1 is a salt-sensitive antimicrobial peptide present in epithelia of the lung and urogenital tract. Infect Immun (1998) 1.59
Mouse beta-defensin 3 is an inducible antimicrobial peptide expressed in the epithelia of multiple organs. Infect Immun (1999) 1.58
Electrostatic binding of proteins to membranes. Theoretical predictions and experimental results with charybdotoxin and phospholipid vesicles. Biophys J (1997) 1.58
Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection. PLoS Pathog (2011) 1.46
The role of chloride anion and CFTR in killing of Pseudomonas aeruginosa by normal and CF neutrophils. J Leukoc Biol (2008) 1.46
Antimicrobial defensin peptides of the human ocular surface. Br J Ophthalmol (1999) 1.44
Defensin expression by the cornea: multiple signalling pathways mediate IL-1beta stimulation of hBD-2 expression by human corneal epithelial cells. Invest Ophthalmol Vis Sci (2003) 1.39
Human neutrophils kill Bacillus anthracis. PLoS Pathog (2005) 1.38
Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity. Protein Sci (2001) 1.29
Mechanisms of renal damage owing to infection. Pediatr Nephrol (2005) 1.21
Host defense peptides in the oral cavity and the lung: similarities and differences. J Dent Res (2008) 1.19
Importance of nitric oxide synthase in the control of infection by Bacillus anthracis. Infect Immun (2006) 1.18
Topical antimicrobials for burn wound infections. Recent Pat Antiinfect Drug Discov (2010) 1.17
Innate immune peptide LL-37 displays distinct expression pattern from beta-defensins in inflamed gingival tissue. Clin Exp Immunol (2006) 1.14
Protective role of Bacillus anthracis exosporium in macrophage-mediated killing by nitric oxide. Infect Immun (2007) 1.12
Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns. Antimicrob Agents Chemother (2002) 1.11
Human alpha-defensins HNPs-1, -2, and -3 in renal cell carcinoma: influences on tumor cell proliferation. Am J Pathol (2002) 1.10
Expression of human beta-defensins in conjunctival epithelium: relevance to dry eye disease. Invest Ophthalmol Vis Sci (2003) 1.09
The iron-siderophore transporter FhuA is the receptor for the antimicrobial peptide microcin J25: role of the microcin Val11-Pro16 beta-hairpin region in the recognition mechanism. Biochem J (2005) 1.09
Induction of epithelial chloride secretion by channel-forming cryptdins 2 and 3. Proc Natl Acad Sci U S A (1997) 1.08
Antimycobacterial agent based on mRNA encoding human beta-defensin 2 enables primary macrophages to restrict growth of Mycobacterium tuberculosis. Infect Immun (2001) 1.08
Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides. Retrovirology (2005) 1.07
Epithelial cell secretions from the human female reproductive tract inhibit sexually transmitted pathogens and Candida albicans but not Lactobacillus. Mucosal Immunol (2010) 1.04
Streptococcal histone-like protein: primary structure of hlpA and protein binding to lipoteichoic acid and epithelial cells. Infect Immun (1998) 1.04
Defensins and other antimicrobial peptides at the ocular surface. Ocul Surf (2004) 1.00
Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics. Pharmaceuticals (Basel) (2013) 0.98
An essential amino acid induces epithelial beta -defensin expression. Proc Natl Acad Sci U S A (2000) 0.98
On the physiology and pathophysiology of antimicrobial peptides. Mol Med (2008) 0.93
Molecular cloning and characterization of rat genes encoding homologues of human beta-defensins. Infect Immun (1999) 0.92
Defensins impair phagocytic killing by neutrophils in biomaterial-related infection. Infect Immun (1999) 0.89
Rhesus monkey (Macaca mulatta) mucosal antimicrobial peptides are close homologues of human molecules. Clin Diagn Lab Immunol (2001) 0.89
Antennae hold a key to Varroa-sensitive hygiene behaviour in honey bees. Sci Rep (2015) 0.89
Hepcidin expression in human airway epithelial cells is regulated by interferon-γ. Respir Res (2011) 0.88
In vitro activity of human beta-defensin 2 against Pseudomonas aeruginosa in the presence of tear fluid. Antimicrob Agents Chemother (2007) 0.88
Survival of Lactobacillus casei in the human digestive tract after consumption of fermented milk. Appl Environ Microbiol (2006) 0.87
Expression of CRAMP via PGN-TLR-2 and of alpha-defensin-3 via CpG-ODN-TLR-9 in corneal fibroblasts. Br J Ophthalmol (2006) 0.86
The role of inflammation in the genesis of the cystic component of craniopharyngiomas. Childs Nerv Syst (2010) 0.86
The potential role of increasing the release of mouse β- defensin-14 in the treatment of osteomyelitis in mice: a primary study. PLoS One (2014) 0.86
Effect of hyperosmolality on beta-defensin gene expression by human corneal epithelial cells. Cornea (2006) 0.85
Reproductive tissue-specific expression profiling and genetic variation across a 19 gene bovine β-defensin cluster. Immunogenetics (2011) 0.84
Inter-population variability of DEFA3 gene absence: correlation with haplotype structure and population variability. BMC Genomics (2007) 0.84
Contribution of alpha- and beta-defensins to lung function decline and infection in smokers: an association study. Respir Res (2006) 0.83
Comprehensive defensin assay for saliva. Anal Chem (2009) 0.81
Regulation of antimicrobial peptide gene expression by nutrients and by-products of microbial metabolism. Eur J Nutr (2012) 0.81
Killing of Bacillus spores is mediated by nitric oxide and nitric oxide synthase during glycoconjugate-enhanced phagocytosis. Glycoconj J (2009) 0.81
Antimycobacterial activity of Pichia pastoris-derived mature bovine neutrophil β-defensins 5. Eur J Clin Microbiol Infect Dis (2014) 0.77
L-isoleucine-supplemented oral rehydration solution in the treatment of acute diarrhoea in children: a randomized controlled trial. J Health Popul Nutr (2011) 0.77
Elevated Concentration of Defensins in Hepatitis C Virus-Infected Patients. J Immunol Res (2016) 0.75
Lactobacillus paracasei modulates the immune system of Galleria mellonella and protects against Candida albicans infection. PLoS One (2017) 0.75
A screen for genetic suppressor elements of hepatitis C virus identifies a supercharged protein inhibitor of viral replication. PLoS One (2013) 0.75
The immunological benefit of higher dose N-acetyl cysteine following mechanical ventilation in critically ill patients. Daru (2014) 0.75
Defensins: The Case for Their Use against Mycobacterial Infections. J Immunol Res (2016) 0.75
Expression of human beta defensins (HBDs) 1, 2 and 3 in gingival crevicular fluid of patients affected by localized aggressive periodontitis. Saudi Dent J (2013) 0.75
Role of Streptococcus mutans two-component systems in antimicrobial peptide resistance in the oral cavity. Jpn Dent Sci Rev (2017) 0.75
Interaction of Candida albicans with human leukocytes and serum. J Bacteriol (1969) 9.19
Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest (1985) 8.63
Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J Clin Invest (1969) 7.61
Purification and antibacterial activity of antimicrobial peptides of rabbit granulocytes. Infect Immun (1984) 5.30
Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy. Ann Intern Med (1978) 4.15
Phagocytosis by human monocytes. Blood (1968) 3.96
Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc Natl Acad Sci U S A (1990) 3.90
Primary structures of three human neutrophil defensins. J Clin Invest (1985) 3.70
Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils. J Biol Chem (1985) 3.58
Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother (1998) 3.45
Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett (1996) 3.39
Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett (1993) 3.30
Antifungal effects of peroxidase systems. J Bacteriol (1969) 3.24
Microbicidal cationic proteins in rabbit alveolar macrophages: a potential host defense mechanism. Infect Immun (1980) 3.13
Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc Natl Acad Sci U S A (1998) 3.02
Primary structures of MCP-1 and MCP-2, natural peptide antibiotics of rabbit lung macrophages. J Biol Chem (1983) 3.00
Direct inactivation of viruses by human granulocyte defensins. J Virol (1986) 3.00
Defensins. Eur J Haematol (1990) 2.88
Nonoxidative fungicidal mechanisms of mammalian granulocytes: demonstration of components with candidacidal activity in human, rabbit, and guinea pig leukocytes. Infect Immun (1975) 2.68
NADPH oxidase deficiency in X-linked chronic granulomatous disease. J Clin Invest (1975) 2.62
Defensins. Curr Opin Immunol (1994) 2.55
Crystallization of antimicrobial pores in membranes: magainin and protegrin. Biophys J (2000) 2.41
Cryptdins: antimicrobial defensins of the murine small intestine. Infect Immun (1992) 2.39
Cyclic 3',5'-adenosine monophosphate in the human lukocyte: synthesis, degradation, andeffects n neutrophil candidacidal activity. J Clin Invest (1971) 2.35
Antibacterial activity of microbicidal cationic proteins 1 and 2, natural peptide antibiotics of rabbit lung macrophages. Infect Immun (1983) 2.33
Direct inactivation of viruses by MCP-1 and MCP-2, natural peptide antibiotics from rabbit leukocytes. J Virol (1985) 2.31
The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms. J Clin Invest (1975) 2.26
Functional aspects of a second mechanism of candidacidal activity by human neutrophils. J Clin Invest (1972) 2.25
Defensins and other endogenous peptide antibiotics of vertebrates. J Leukoc Biol (1995) 2.25
Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun (2000) 2.24
Susceptibility of Chlamydia trachomatis to protegrins and defensins. Infect Immun (1996) 2.16
Effects of cholera enterotoxin on adenosine 3',5'-monophosphate and neutrophil function. Comparison with other compounds which stimulate leukocyte adenyl cyclase. J Clin Invest (1973) 2.16
Assessment of chlorination by human neutrophils. Nature (1983) 2.12
Activity of rabbit leukocyte peptides against Candida albicans. Infect Immun (1985) 2.05
Development of amphotericin B-resistant Candida tropicalis in a patient with defective leukocyte function. Am J Med Sci (1979) 2.02
Mouse neutrophils lack defensins. Infect Immun (1992) 2.01
In vitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytes. Blood (1986) 2.01
Antimicrobial peptides of vertebrates. Curr Opin Immunol (1998) 1.94
Correlation of binding of rabbit granulocyte peptides to Candida albicans with candidacidal activity. Infect Immun (1985) 1.89
Neutrophil defensins: purification, characterization, and antimicrobial testing. Methods Enzymol (1994) 1.88
Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes. Chem Biol (1996) 1.87
In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J Infect Dis (1986) 1.84
Designer assays for antimicrobial peptides. Disputing the "one-size-fits-all" theory. Methods Mol Biol (1997) 1.79
Fungicidal activity of rabbit alveolar and peritoneal macrophages against Candida albicans. Infect Immun (1980) 1.79
Rubidium release: a rapid and sensitive assay for amphotericin B. J Infect Dis (1976) 1.76
Bactericidal properties of murine intestinal phospholipase A2. J Clin Invest (1995) 1.75
Phagolysosomal pH of human neutrophils. Blood (1984) 1.75
Effects of pH and salinity on the antimicrobial properties of clavanins. Infect Immun (1997) 1.75
Susceptibility of Neisseria gonorrhoeae to protegrins. Infect Immun (1996) 1.65
Membrane thinning effect of the beta-sheet antimicrobial protegrin. Biochemistry (2000) 1.64
Mechanism of target cytolysis by peptide defensins. Target cell metabolic activities, possibly involving endocytosis, are crucial for expression of cytotoxicity. J Immunol (1988) 1.64
Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and "specific" granule deficiency. J Clin Invest (1988) 1.63
Microbicidal cationic proteins of rabbit alveolar macrophages: amino acid composition and functional attributes. Infect Immun (1981) 1.61
Fungicidal properties of a chymotrypsin-like cationic protein from human neutrophils: adsorption to Candida parapsilosis. Infect Immun (1977) 1.61
Isolation and characterization of human defensin cDNA clones. Proc Natl Acad Sci U S A (1988) 1.61
Defensin-rich dense granules of human neutrophils. Blood (1987) 1.59
Arginine-rich cationic proteins of human eosinophil granules: comparison of the constituents of eosinophilic and neutrophilic leukocytes. Lab Invest (1977) 1.57
Defensins: a family of antimicrobial and cytotoxic peptides. Toxicology (1994) 1.53
Increased content of microbicidal cationic peptides in rabbit alveolar macrophages elicited by complete Freund adjuvant. Infect Immun (1981) 1.52
Antimicrobial proteins of murine macrophages. Infect Immun (1993) 1.50
Antimicrobial activity of phagocyte granule proteins. Semin Respir Infect (1986) 1.49
Purification and antimicrobial properties of three defensins from rat neutrophils. Infect Immun (1989) 1.46
Intramolecular disulfide bonds enhance the antimicrobial and lytic activities of protegrins at physiological sodium chloride concentrations. Eur J Biochem (1996) 1.45
Antibiotic peptides from higher eukaryotes: biology and applications. Mol Med Today (1999) 1.44
D-amino acid oxidase in leukocytes: a possible D-amino-acid-linked antimicrobial system. Proc Natl Acad Sci U S A (1969) 1.43
Phagocytosis by human eosinophils. Blood (1968) 1.42
Myeloperoxidase deficiency. Immunologic study of a genetic leukocyte defect. N Engl J Med (1970) 1.41
Uteroglobin/Clara cell 10-kDa family of proteins: nomenclature committee report. Ann N Y Acad Sci (2000) 1.41
Effects of colchicine and chloramphenicol on the oxidative metabolism and phagocytic activity of human neutrophils. J Infect Dis (1973) 1.40
UCLA Conference. Monocytes and macrophages: functions and diseases. Ann Intern Med (1978) 1.38
In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis. Infect Immun (1996) 1.37
In vitro candidastatic properties of the human neutrophil calprotectin complex. J Immunol (1993) 1.37
Multiple states of beta-sheet peptide protegrin in lipid bilayers. Biochemistry (1998) 1.36
Membrane channel formation by antimicrobial protegrins. Biochim Biophys Acta (1999) 1.36
Individual and synergistic effects of rabbit granulocyte proteins on Escherichia coli. J Clin Invest (1994) 1.34
Gallinacins: cysteine-rich antimicrobial peptides of chicken leukocytes. FEBS Lett (1994) 1.33
Antimicrobial peptides of leukocytes. Curr Opin Hematol (1997) 1.32
Activity of defensins from human neutrophilic granulocytes against Mycobacterium avium-Mycobacterium intracellulare. Infect Immun (1992) 1.32
Secretory phospholipase A2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears. Infect Immun (1998) 1.31
Inhibition by sulfonamides of the candidacidal activity of human neutrophils. J Clin Invest (1971) 1.30
Defective bactericidal activity in myeloperoxidase-deficient human neutrophils. Nature (1969) 1.29
Human neutrophil antimicrobial activity. Rev Infect Dis (1988) 1.28
Orientation and dynamics of an antimicrobial peptide in the lipid bilayer by solid-state NMR spectroscopy. Biophys J (2001) 1.27
Leukocyte candidacidal activity and resistance to systemic candidiasis in patients with cancer. Cancer (1971) 1.26
NAD(P)H oxidase activity in human neutrophils stimulated by phorbol myristate acetate. J Clin Invest (1980) 1.26
Protegrin structure and activity against Neisseria gonorrhoeae. Infect Immun (1997) 1.25
Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides. Eur J Clin Microbiol Infect Dis (2000) 1.24
Identification of a new member of the protegrin family by cDNA cloning. FEBS Lett (1994) 1.22
Purification of cysteine-rich bioactive peptides from leukocytes by continuous acid-urea-polyacrylamide gel electrophoresis. Anal Biochem (1993) 1.21
The structure of porcine protegrin genes. FEBS Lett (1995) 1.19
Newborn rabbit alveolar macrophages are deficient in two microbicidal cationic peptides, MCP-1 and MCP-2. Am Rev Respir Dis (1985) 1.17
Protegrins: new antibiotics of mammalian origin. Expert Opin Investig Drugs (2000) 1.15
In vitro sensitivity of oral, gram-negative, facultative bacteria to the bactericidal activity of human neutrophil defensins. Infect Immun (1990) 1.13
Circular minidefensins and posttranslational generation of molecular diversity. J Leukoc Biol (2001) 1.12
Characterization of defensin precursors in mature human neutrophils. Blood (1992) 1.12
An enzyme immunoassay for human defensins. J Immunol Methods (1991) 1.12
Receptor-mediated regulation of superoxide production in human neutrophils stimulated by phorbol myristate acetate. J Clin Invest (1981) 1.10
Refractory megaloblastic anemia with myeloperoxidase-deficient neutrophils. Ann Intern Med (1972) 1.09
Beta-sheet antibiotic peptides as potential dental therapeutics. Int J Antimicrob Agents (1998) 1.09
Prophenin-1, an exceptionally proline-rich antimicrobial peptide from porcine leukocytes. FEBS Lett (1995) 1.09